Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor
作者： Sung Soo Jun , Ja Seong Koo , Jae Woon Son , Sung Wuk Kim , Young Gwan Jo
DOI:
关键词: Active ingredient 、 HMG-CoA reductase 、 Combination therapy 、 Angiotensin receptor 、 Biochemistry 、 Non-competitive inhibition 、 Pharmacology 、 Reductase 、 Chemistry
摘要: Disclosed herein is a combination therapy and preparation of an angiotensin-II-receptor blocker HMG-CoA reductase inhibitor characterized in that the absorbed substantially later than inhibitor. As are released at different times, present prevents competitive inhibition between two drugs side effects, as well simultaneously provides synergistic effects for each active ingredient convenience taking drugs.
lens.org 参考文章(5)
Sung Soo Jun, Ja Seong Koo, Jae Woon Son, Sung Wuk Kim, Young Gwan Jo, Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors ,(2007)
David John Carini, John Jonas Vytautas Duncia, Angiotensin II receptor blocking imidazoles ,(1987)
Niall M. M. Fanning, Paul Stark, John G. Devane, Multiparticulate modified release composition ,(1999)
Jong Soo Woo, Yong Il Kim, Moon Hyuk Chi, Complex formulation of 3-hydroxy-3-methyl glutaryl coa reductase inhibitor and antihypertensive agent, and process for preparing same ,(2005)
Hiroshi Tomiyama, Akira Tomiyama, Keiichiro Hayashi, Hidetoshi Miyamoto, Seiichiro Mochizuki, Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia ,(2004)